MoCRA: What the Push for Full Implementation Means for Your Skincare
The Modernization of Cosmetics Regulation Act, commonly called MoCRA, is [...]
By Dr. Jane Yoo|2026-07-25T04:44:46+00:00July 25th, 2026|Categories: Skincare Products|Tags: cosmetics industry regulation 2026, cosmetics ingredient transparency, cosmetics safety law, FDA cosmetics oversight, Good Manufacturing Practices skincare, MoCRA cosmetics regulation, Personal Care Products Council|Comments Off on MoCRA: What the Push for Full Implementation Means for Your Skincare
When AI Silently Transcribes Your Visit: What a Recent Lawsuit Means for Dermatology Practices
Ambient AI scribes listen to conversations between clinicians and patients [...]
By Dr. Jane Yoo|2026-07-25T04:41:26+00:00July 25th, 2026|Categories: Technology|Tags: AI clinical documentation, AI medical scribe consent, ambient AI dermatology, dermatology patient privacy, dermatology practice technology, healthcare AI lawsuit, medical record confidentiality, patient consent dermatology|Comments Off on When AI Silently Transcribes Your Visit: What a Recent Lawsuit Means for Dermatology Practices
Olive Young Has Landed in the U.S.: What Its American Launch Means for K-Beauty
If you follow K-beauty, you probably already know Olive Young, [...]
By Dr. Jane Yoo|2026-07-25T04:38:23+00:00July 25th, 2026|Categories: Social Media Trends|Tags: centella asiatica skincare, K-beauty market growth, K-beauty retail, K-beauty shopping guide, Korean beauty trends 2026, Korean sunscreen, Olive Young US launch, Sephora K-beauty partnership, snail mucin|Comments Off on Olive Young Has Landed in the U.S.: What Its American Launch Means for K-Beauty
VDPHL01: A Potential Oral Treatment for Female Pattern Hair Loss
For more than 30 years, topical minoxidil has been the [...]
By Dr. Jane Yoo|2026-07-25T04:35:43+00:00July 25th, 2026|Categories: Aesthetic Innovations|Tags: androgenetic alopecia treatment, female pattern hair loss treatment, FPHL clinical trial results, hair regrowth pill, oral minoxidil, Rogaine alternative, VDPHL01, Veradermics, women's hair loss FDA approval|Comments Off on VDPHL01: A Potential Oral Treatment for Female Pattern Hair Loss
The FDA’s Warning on RF Microneedling: What Patients Should Know
In October 2025, the FDA issued a safety communication about [...]
By Dr. Jane Yoo|2026-07-25T04:33:14+00:00July 25th, 2026|Categories: Aesthetic Innovations|Tags: at-home microneedling dangers, cosmetic procedure safety, dermatology device safety, FDA safety warning, microneedling complications, radiofrequency microneedling, RF microneedling risks, skin tightening treatment risks|Comments Off on The FDA’s Warning on RF Microneedling: What Patients Should Know
Squalane vs. Squalene: What’s the Difference, and Why Does It Matter for Your Skin?
Squalene: What Your Skin Already Makes Squalene, with an "e," [...]
By Dr. Jane Yoo|2026-07-25T04:28:52+00:00July 25th, 2026|Categories: Skincare Products|Tags: lightweight facial oils, non-comedogenic oils, plant-derived squalane, silicone alternative skincare, skin barrier ingredients, squalane skincare benefits, squalane vs squalene, what is hemisqualane|Comments Off on Squalane vs. Squalene: What’s the Difference, and Why Does It Matter for Your Skin?
Dr. Jane Yoo
Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York.
Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech.
Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.





